Login

Suven Life Sciences Ltd.

₹260.57

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Suven Life Sciences Ltd.

  • NSE : SUVEN

₹260.57

₹260.57

13.55 (5.49%) - 12 Jun 2025 04:11 PM
  • NSE : SUVEN

About Company

Suven Life Sciences provides wide range of Drug Discovery and Development Support Services (DDDSS) to global Pharma and Biotech companies. Suven has state-of-art facilities with highly qualified & experienced team of scientists. Suven offer research services specializing in Synthetic, Medicinal and Analytical Chemistry, In-vitro Assay development and Screening, Drug Metabolism & Pharmacokinetics, CNS Pharmacology (Behavioral Pharmacology, Microdialysis, Receptor Occupancy, Electrophysiology), Toxicology and Safety Pharmacology, Bioanalysis, and NCE Formulations.

Market Cap. ₹ 5,095 Cr.
52 Week - High/Low ₹ 250/95
P/E Ratio
P/B Ratio 6.04
Enterprise Value ₹ 5,110 Cr.
ROE % -0.94
RSI Value 68.84
EMA 50 175.62
EMA 200 140.02
Market Cap. ₹ 5,095 Cr.
52 Week - High/Low ₹ 250/95
P/E Ratio
P/B Ratio 18.92
Enterprise Value ₹ 5,096 Cr.
ROE % -32.56
RSI Value 68.84
EMA 50 175.62
EMA 200 140.02
Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.